# John Ricciardi

John Ricciardi is a recruiter focused on senior Regulatory Affairs roles in life sciences. His posts discuss how companies can plan specialist searches, assess narrow candidate markets, and connect hiring timelines to drug-development milestones.

- Profile: https://b2binfluencer.marketing/creators/john-ricciardi/
- LinkedIn: https://www.linkedin.com/in/johnricciardi
- LinkedIn followers: 13,852
- Median of last 7 posts: 8 reactions, 0 comments (checked 2026-11-02)
- Topics: artificial-intelligence, recruiting
- Based on 8 dated posts, latest 2026-09-28

## Summary

John Ricciardi is most useful for explaining senior Regulatory Affairs hiring and search timing in life sciences.

- Best for: A specialist regulatory affairs search firm or life sciences recruitment practice commissioning thought leadership for biotech executives.
- Not for: A hiring technology vendor seeking AI detection claims, or a broad-reach consumer or lifestyle sponsorship.
- Check first: Confirm audience composition and whether paid partnership formats or terms exist.

### Takeaways

- Map the Regulatory Affairs market before a role becomes urgent.
- Layoff headlines do not mean a deep pool of qualified specialists.
- An open regulatory seat is a program risk, not just a hiring delay.

## Main ideas

- **Start mapping the market long before you need to hire**: Ricciardi argues that the worst week to begin mapping the Regulatory Affairs market is the week a company suddenly needs someone. Once capital arrives, milestones and expectations tighten, and the profile a company needs usually becomes more specific. Starting early does not mean hiring early: a company can learn the market, identify people who might fit months out, find out what would attract them, and test whether the profile it agreed on internally exists in the numbers leadership assumed. Waiting does not create more candidates; it only reduces the room to make a good decision.
- **Layoff headlines do not equal a deep pool of qualified specialists**: Ricciardi separates the number of applicants from the number of people who have actually done the work a company needs, are available, and would consider leaving a current job. Where the requirement involves a particular therapeutic background, specific FDA experience, or a history of taking a program through the relevant stage, the candidate market may still be very small. The conclusion is that a larger candidate pool does not necessarily make a difficult search easier, and that hiring plans built on layoff headlines can misread the market.
- **An open regulatory seat is a program risk, not just a hiring delay**: Several posts argue that a senior regulatory strategist or highly specialised CMC hire can still take six to nine months to fill, and that a development program does not pause while the search runs. Deliverables, FDA interactions, submission timelines and investor reporting continue. The proposed fix is to put the search timeline alongside the program timeline and plan before the need becomes urgent; misreading the talent market eventually becomes a program problem, not just a longer search.
- **Regulatory leaders are hired to interpret FDA uncertainty**: Ricciardi describes emerging biotech companies building development plans around expected agency timing, with investors watching for progress and a fixed runway. If the FDA takes longer than expected, or comes back asking for something that changes the plan, the regulatory leader's experience becomes central: understanding what the agency is asking, what it means for the program, and how to help the rest of the organisation make decisions. The consequences, the post notes, reach beyond the Regulatory Affairs department. This is the subject matter behind the hiring advice.
- **Functional leaders have to translate why a specialist role is genuinely hard to fill**: One post isolates an internal communication problem rather than a market one. The functional leader knows why a specific requirement is essential, while senior leadership reads layoff headlines and wonders why the hire should still be difficult. The leader has to explain what makes the need unique, how small the relevant candidate population may be, and why waiting until the seat is already open creates a harder problem — and may not have direct access to the board or C-suite to make that case.
- **AI-era screening: get past the document instead of trying to detect the tool**: Ricciardi notes that AI can turn a background into a strong résumé in seconds and can make experience sound better than reality, to the point where an experienced recruiter probably cannot reliably spot an AI-written document. The argument is that becoming an AI detective is the wrong goal; the useful skill is knowing a field well enough to move beyond the document. A résumé shows what someone claims to have done, while a real conversation gives a better sense of whether they did it — which makes functional expertise more important, not less.

## Work to read

- [Can an experienced recruiter still spot an AI-written résumé?](https://www.linkedin.com/posts/johnricciardi_when-i-started-recruiting-we-mailed-resumes-activity-7510360316405342208-mM7f)
- [The wrong week to start mapping the Regulatory Affairs market](https://www.linkedin.com/posts/johnricciardi_the-worst-time-to-start-mapping-the-regulatory-activity-7508548425328566273-VvCM)
- [Layoffs do not equal a bigger qualified candidate pool](https://www.linkedin.com/posts/johnricciardi_ive-been-doing-this-for-close-to-30-years-activity-7516883154822021121-OYFp)
- [Where would the program be if the leadership seat were still open in six months?](https://www.linkedin.com/posts/johnricciardi_if-a-regulatory-affairs-leadership-seat-opened-activity-7518695238929068033-Xlu6)
- [FDA uncertainty and why regulatory leadership matters more during it](https://www.linkedin.com/posts/johnricciardi_theres-a-lot-of-uncertainty-around-fda-interactions-activity-7518332860664262656-3Gk6)
- [A family post about the 'us' that survives kids growing up](https://www.linkedin.com/posts/johnricciardi_my-wife-and-i-asked-my-daughter-if-she-could-activity-7516158421306351617-tjlZ)

## Partnerships

The reviewed material does not document any sponsorship or paid-partnership formats for John Ricciardi. Across nine LinkedIn posts, there is no media kit, rate card, sponsored-placement example, or public partnership inquiry route. What the posts do show is a working recruiting practice: Ricciardi writes about senior Regulatory Affairs searches, the narrowness of specialist candidate markets, and how hiring timelines interact with drug-development milestones, and in one post he refers to the clients he served when he started in recruiting and to how he now evaluates candidates beyond the resume. That suggests a service business built on recruiting engagements rather than a publisher selling sponsored slots, but the posts stop short of describing commercial terms, so no format can be stated as an available offer. For a buyer, the practical implication is that any partnership would have to be discussed directly as a custom engagement rather than selected from a published menu, and its scope, deliverables, and disclosure terms cannot be verified from the reviewed evidence.

## Alternatives

- Monica Stone: Choose Stone when the brief moves off regulatory-affairs search timing and onto the recruiting process itself. Her posts work from published research on AI reshaping work and on application volume: HBR's trends piece on roles changing faster than job descriptions, managers carrying more complexity, and culture as a competitive advantage, and an SHRM report arguing that AI has made applying so easy that the signal disappears. If the firm's goal is a piece about restoring signal in a clogged pipeline, designing better screening checkpoints instead of processing more resumes, or how hiring managers absorb AI while running hybrid teams, Stone's argument-plus-question format covers that ground directly. The same buyer, a life sciences recruitment firm, would get a stronger piece by switching the topic from specialist market depth to process design under AI volume.
- Judy Schramm: Choose Schramm when the campaign objective is attracting senior candidates rather than explaining the specialist market to executives. Her posts argue that strong candidates research a company before interviewing, checking the company page, Glassdoor, who else works there, and the CEO's LinkedIn profile, and that most CEO profiles fail to show how a leader thinks or how they lead. A visible leadership presence, in her framing, gets the right people excited before they apply. For a recruitment firm whose brief is executive visibility or employer brand for hard-to-fill leadership roles, Schramm's material addresses that task more directly than a search-timing argument would.
- Michael Cleary: Choose Cleary when the campaign is really about the firm's own digital presence rather than about hiring commentary. His posts argue that traffic is not the measure of a working website, that lower traffic with better-qualified enquiries is a stronger signal, and that a website now does early sales, recruiting, client education, brand perception, and increasingly feeds search engines and AI tools that form an opinion before a person reaches the site. If the life sciences recruitment firm wants a piece on making its website recruit and convert, or on which metrics show real buying intent, Cleary's material maps onto that task more cleanly than a market-timing argument would.

---
AI-assisted summary of public posts. Audience demographics are not available. Engagement appears only where we checked recent posts. Method: https://b2binfluencer.marketing/methodology/